Logo

IonPath: Brad Nelson

Jun 17, 2020

IonPath has appointed Brad Nelson as senior vice president of marketing and corporate strategy. Nelson will lead marketing, product management, and application functions related to the company's multiplexed ion beam Imaging technology. Nelson most recently served as VP of marketing at Magnolia Medical Technologies. Prior to that he was head of marketing and director of corporate development at Labcyte (now part of Danaher). He also previously led marketing efforts at Velocity11, which was acquired by Agilent.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.